The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...

On the other hand, common protein-based vaccines are safe but generally not as effective. This new virus-like particle vaccine can maximize immune responses because it mimics the virus structure while ...

Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, ...

The CEPI-CPI partnership supports the 100 Days Mission—a goal embraced by leaders of the G7 and G20 to reduce vaccine development timelines to a little over three months in response to a pandemic ...

while also augmenting vaccine immunogenicity. Virus-like particle vaccines (VLPs), given their structural resemblance to viruses, are deemed a highly promising class of protective vaccines. The ...

HPV: Human papillomavirus; VLP: Virus-like particle. Data from [16,73 ... (regardless of serostatus or HPV DNA PCR status to vaccine-relevant HPV types at study entry, regardless of entry ...

The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines.

"We're still learning a lot about norovirus vaccines and how they might protect," says Atmar. "We know that administration of virus-like particle (VLP)-based vaccines via the nose or by ...

Wisconsin Sen. Ron Johnson stated, “There's never been a placebo-controlled study on childhood vaccines." That's false.

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have been assigned an average rating of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat reports. Five ...